2 Biotech Stocks Focused on Fighting the Coronavirus That Could Double in Price

This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEAB20I9_M.jpg

But equally worrisome, some studies suggest that COVID-19 infection can lead to long-haul symptoms even for people that are vaccinated. Consequently, several biotech companies have been working on therapies to combat the lingering effects of the virus.

Humanigen, Inc. (HGEN) and AIM ImmunoTech Inc. (AIM) are two lesser-known biotech companies that are making significant progress in devising solutions to fight the long-term effects of COVID-19. So, we think it could be wise to add these two stocks to your watch list now. Wall Street analysts expect their shares to more than double in price in the near term.

Continue reading on StockNews